RFK Jr. targets childhood psychiatric drugs; doctors push back
- The Trump administration has launched an investigation into the over-prescription of pharmaceuticals for children, led by Health and Human Services Secretary Robert F. Kennedy Jr.
- A 2024 study noted a 43% increase in antidepressant prescriptions for teens aged 12 to 17 between 2016 and 2022, particularly after COVID-19.
- Kennedy expressed concerns about the risks of overmedication and stated, '15% of American youth are now on Adderall or some other ADHD medication.'
- Some medical professionals worry that the investigation may create fear over necessary medications, highlighting concerns from organizations like the American Academy of Child and Adolescent Psychiatry.
7 Articles
7 Articles
RFK Jr. targets childhood psychiatric drugs; doctors push back
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has made psychiatric medications a focus of his review of the country’s childhood chronic disease crisis, claiming they’ve been “insufficiently scrutinized” and are addictive. Childhood psychiatrists insist the drugs, for attention-deficit/hyperactivity disorder (ADHD) and depression, are nonaddictive and proven safe and say they are more…
Coverage Details
Bias Distribution
- 67% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage